The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early Outcomes
Category: Ankle; Other Introduction/Purpose: The Invision talar component was launched in 2018 as a revision total ankle arthroplasty (TAA) specific option geared towards avoiding further subsidence when poor talar bone stock is present. Due to the recency of the market- availability of the Invision...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-12-01
|
| Series: | Foot & Ankle Orthopaedics |
| Online Access: | https://doi.org/10.1177/2473011423S00431 |
| _version_ | 1797375220153057280 |
|---|---|
| author | Alexandra Krez BA Albert T. Anastasio MD Bruno N. Valan BS Billy I. Kim MD James K. DeOrio MD James A. Nunley MD Mark Easley MD Samuel Adams MD |
| author_facet | Alexandra Krez BA Albert T. Anastasio MD Bruno N. Valan BS Billy I. Kim MD James K. DeOrio MD James A. Nunley MD Mark Easley MD Samuel Adams MD |
| author_sort | Alexandra Krez BA |
| collection | DOAJ |
| description | Category: Ankle; Other Introduction/Purpose: The Invision talar component was launched in 2018 as a revision total ankle arthroplasty (TAA) specific option geared towards avoiding further subsidence when poor talar bone stock is present. Due to the recency of the market- availability of the Invision, studies evaluating the efficacy of the implant, even in the short-term, are lacking. Thus, the purpose of this study was to present the early-term outcomes of a series of patients undergoing revision TAA with the use of the Invision talar component. Methods: This was a single-center, retrospective review of 28 patients undergoing revision TAA with the Invision talar component and Inbone II tibial component (Wright Medical; Memphis, Tennessee) performed between 2007 and 2022. Mean follow-up was 1.3 ± 0.93 years. Data on patient preoperative characteristics, postoperative complications, and survivorship were collected. The primary outcome measures were time to major complication, reoperation, and infection. Results: The most common concurrent procedures performed with revision TAA with the Invision talar component were gastrocnemius recession (n=14, 50%), subtalar arthrodesis (n=3, 10.7%) and cotton osteotomy (n = 1, 3.6%). The mean preoperative coronal deformity off the tibia was 4.07 ± 3.06 degrees for varus and 3.67 ± 4.36 degrees for valgus deformities, respectively, and postoperatively, was 1.67 ± 2.16 degrees for varus and 2.00 ± 3.48 degrees for valgus. The mean preoperative coronal plane deformity off the talus was 4.83 ± 6.68 degrees for varus and 4.22 ± 4.21 degrees for valgus, respectively, and postoperatively, was 1.23 ± 2.45 degrees for varus and 2.32 ± 3.93 degrees for valgus. The survivorship from any complication, major complication, reoperation, and infection is shown in Table 2. Conclusion: In a series of 28 patients undergoing revision TAA with the Invision talar component and Inbone II tibial component, we demonstrate a survivorship of 92.7% at 1-year follow up. The Invision appears to have a reasonable safety profile in this non- designer series. The implant compares favorably with others utilized in the revision TAA setting at the early-term, but further studies evaluating mid-and long-term outcomes are required to fully assess the efficacy of the Invision. |
| first_indexed | 2024-03-08T19:19:07Z |
| format | Article |
| id | doaj.art-0a850f4e4818443bb9759d9632314d1c |
| institution | Directory Open Access Journal |
| issn | 2473-0114 |
| language | English |
| last_indexed | 2024-03-08T19:19:07Z |
| publishDate | 2023-12-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Foot & Ankle Orthopaedics |
| spelling | doaj.art-0a850f4e4818443bb9759d9632314d1c2023-12-26T19:04:25ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142023-12-01810.1177/2473011423S00431The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early OutcomesAlexandra Krez BAAlbert T. Anastasio MDBruno N. Valan BSBilly I. Kim MDJames K. DeOrio MDJames A. Nunley MDMark Easley MDSamuel Adams MDCategory: Ankle; Other Introduction/Purpose: The Invision talar component was launched in 2018 as a revision total ankle arthroplasty (TAA) specific option geared towards avoiding further subsidence when poor talar bone stock is present. Due to the recency of the market- availability of the Invision, studies evaluating the efficacy of the implant, even in the short-term, are lacking. Thus, the purpose of this study was to present the early-term outcomes of a series of patients undergoing revision TAA with the use of the Invision talar component. Methods: This was a single-center, retrospective review of 28 patients undergoing revision TAA with the Invision talar component and Inbone II tibial component (Wright Medical; Memphis, Tennessee) performed between 2007 and 2022. Mean follow-up was 1.3 ± 0.93 years. Data on patient preoperative characteristics, postoperative complications, and survivorship were collected. The primary outcome measures were time to major complication, reoperation, and infection. Results: The most common concurrent procedures performed with revision TAA with the Invision talar component were gastrocnemius recession (n=14, 50%), subtalar arthrodesis (n=3, 10.7%) and cotton osteotomy (n = 1, 3.6%). The mean preoperative coronal deformity off the tibia was 4.07 ± 3.06 degrees for varus and 3.67 ± 4.36 degrees for valgus deformities, respectively, and postoperatively, was 1.67 ± 2.16 degrees for varus and 2.00 ± 3.48 degrees for valgus. The mean preoperative coronal plane deformity off the talus was 4.83 ± 6.68 degrees for varus and 4.22 ± 4.21 degrees for valgus, respectively, and postoperatively, was 1.23 ± 2.45 degrees for varus and 2.32 ± 3.93 degrees for valgus. The survivorship from any complication, major complication, reoperation, and infection is shown in Table 2. Conclusion: In a series of 28 patients undergoing revision TAA with the Invision talar component and Inbone II tibial component, we demonstrate a survivorship of 92.7% at 1-year follow up. The Invision appears to have a reasonable safety profile in this non- designer series. The implant compares favorably with others utilized in the revision TAA setting at the early-term, but further studies evaluating mid-and long-term outcomes are required to fully assess the efficacy of the Invision.https://doi.org/10.1177/2473011423S00431 |
| spellingShingle | Alexandra Krez BA Albert T. Anastasio MD Bruno N. Valan BS Billy I. Kim MD James K. DeOrio MD James A. Nunley MD Mark Easley MD Samuel Adams MD The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early Outcomes Foot & Ankle Orthopaedics |
| title | The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early Outcomes |
| title_full | The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early Outcomes |
| title_fullStr | The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early Outcomes |
| title_full_unstemmed | The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early Outcomes |
| title_short | The Invision Talar Component as a Revision Total Ankle Arthroplasty Option: Analysis of Early Outcomes |
| title_sort | invision talar component as a revision total ankle arthroplasty option analysis of early outcomes |
| url | https://doi.org/10.1177/2473011423S00431 |
| work_keys_str_mv | AT alexandrakrezba theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT alberttanastasiomd theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT brunonvalanbs theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT billyikimmd theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT jameskdeoriomd theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT jamesanunleymd theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT markeasleymd theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT samueladamsmd theinvisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT alexandrakrezba invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT alberttanastasiomd invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT brunonvalanbs invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT billyikimmd invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT jameskdeoriomd invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT jamesanunleymd invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT markeasleymd invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes AT samueladamsmd invisiontalarcomponentasarevisiontotalanklearthroplastyoptionanalysisofearlyoutcomes |